News

Our Healthcare News

Prolacta Bioscience Raises $35 Million in Mezzanine Financing

CITY OF INDUSTRY, Calif. Dec. 6, 2016 – Prolacta Bioscience®, the nation’s leading provider of human milk-based neonatal nutritional products, today announced the closing of…  

Dec 06 2016

Metabolon Raises Additional $15 Million in Funding from Essex Woodlands

RESEARCH TRIANGLE PARK, N.C. – – Metabolon, Inc., the global leader in metabolomics, announced today that it has raised an additional $15 million in funding…  

Dec 05 2016

Metabolon Closes $15 Million Financing to Support Precision Medicine Growth Opportunities

RESEARCH TRIANGLE PARK, N.C. –– Metabolon, Inc., the global leader in metabolomics, announced today that it has closed a financing that raised $15 million from…  

Aug 11 2016

Suneva Appoints Preston Romm to Chief Executive Officer, Fortifies Board with Industry Leaders

SAN DIEGO, California —Suneva Medical, Inc., a privately‐held aesthetics company, today announced the promotion of Preston Romm to president and chief executive officer, effective immediately.…  

Aug 04 2016

Pierre Fabre Pharmaceuticals and Grupo Biotoscana enter into a Commercialization Agreement

Castres (France) and Montevideo (Uruguay) – July 25, 2016 – Pierre Fabre Pharmaceuticals, the second-largest French private pharmaceutical laboratory and Grupo Biotoscana SL (GBT), a…  

Jul 25 2016

Suneva Medical Closes $25 Million Financing to Support Continued Growth Opportunities

San Diego, CA (June 14, 2016)—Suneva Medical, Inc., a privately-held and innovative aesthetics leader, today announced the closing of a $25 million investment by Essex…  

Jun 14 2016

Entellus Medical Announces Presentation of Positive Clinical Results in Pediatric Patients

PLYMOUTH, MN and CHICAGO, IL—Entellus Medical, Inc. (NASDAQ: ENTL) announced today that Dr. Zachary M. Soler, MD, MSc, Medical University of South Carolina, presented the…  

May 19 2016

Endologix Announces CE Mark for Next-Generation Nellix(R) EndoVascular Aneurysm Sealing System

IRVINE, California (GLOBE NEWSWIRE)—Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today achievement of CE (Conformite Europeenne) Mark of the…  

Apr 11 2016

ABIOMED Impella Therapy Receives FDA Approval for Cardiogenic Shock After Heart Attack/Heart Surgery

DANVERS, Massachusetts – April 7, 2016 – Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that it has received…  

Apr 07 2016